Kancera AB (publ) today announces the decision to focus its business on developing the company’s fractalkine blocking candidate drugs KAND567 and KAND145 to treat cardiovascular diseases, initially ...
Recent advancements in nanotechnology have led to a surge of interest in nano and micro devices and systems, such as nanotubes, nano/microstructures, and nanofiber fabrication processes. This progress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback